Spire Corp. (Nasdaq: SPIR) announced that Dr. Christian Dufresne has been appointed to the position of Chief Financial Officer, replacing James F. Parslow. Dr. Dufresne has been with Spire for six years. Most recently, he has served as Vice President - Corporate Planning at Spire Corp., and has previously held the position of Chief Financial Officer of Spire Biomedical. In his role as Vice President - Corporate Planning, Dr. Dufresne has taken a leadership role in defining the strategic direction of the company and also led the company's recent financing. In his new position he will continue to focus on development and execution of strategies for corporate growth.
Roger G. Little, Chairman and CEO of Spire Corp., said, "Chris has demonstrated leadership and fiscal responsibility at Spire, at both the product line and corporate levels. I am confident in his abilities to plan and manage the company's finances."
Dr. Dufresne has a doctorate in economics from Clark University with a concentration in industrial organization and finance. Prior to working with Spire Corp., he was a Consultant for Stratford Associates, a market research firm that performs economic market modeling for Fortune 500 companies. Dr. Dufresne will be supported by a new Chief Accounting Officer, yet to be identified, who will be responsible for all accounting issues including compliance with Sarbanes-Oxley requirements.
